Skip to main content
. 2017 Dec 1;6(1):182–191. doi: 10.1089/biores.2017.0023

FIG. 2.

FIG. 2.

AAV-mediated Gene Delivery. (A) A diagram of the vector constructs used in this study—control vector GFP driven by a CBA promoter (top—AAV-GFP) and therapeutic vector canine PDK4 driven by a CBA promoter (bottom—AAV-PDK4). Both promoter-transgene constructs are situated between AAV ITR to enable viral capsid packaging. (B) Timeline protocol of AAV treatment and fibroblast starvation. (C) Graph showing high level expression of PDK4 RNA transcripts in AAV-PDK4-treated PDK4wt/del and PDK4del/del fibroblasts compared to controls (*p < 0.05 and **p < 0.01 respectively). (D) Graph showing increased PDK4del/del fibroblast viability in starvation conditions following AAV-PDK4 treatment (*p < 0.05). AAV, adeno-associated virus; CBA, chick beta actin; GFP, green fluorescent protein; ITR, inverted terminal repeats.